https://www.news-medical.net/news/20220302/Study-reports-substantial-loss-of-protection-one-month-after-complete-SARS-CoV-2-BNT162b2-immunization-in-children.aspx
0
0
3/2/22 at 12:28pm
Organization
News-Medical.Net
Authors
A new study evaluated the efficacy of Pfizer’s BNT162b2 vaccine in children aged 17 years or younger after the emergence of the SARS-CoV-2 Omicron variant.
Create an account
or login to join the discussion